Myopia Clinical Trial
Official title:
Evaluating the Efficacy of NeuroVisions's NVC Treatment for Low Myopia
The purpose of the present study is to carry out a trial to evaluate the clinical efficacy of
the NeuroVision Low Myopia Treatment.
The specific questions to be answered are:
1. Is there an improvement in vision following the treatment without bringing about a
change in the subject's prescription for glasses?
2. Can any treatment effect be seen at 6 months and 12 months after the termination of the
treatment?
Myopia and its treatment modalities are one of the widely studied areas in vision research.
So far all the treatment options have been optical i.e., patients with myopia are either
corrected with spectacles, contact lenses or refractive surgery to provide clear vision.
NeuroVision's NVC vision correction technology will be a novel method in the treatment of low
myopia as the technology is directed at specific neuronal interactions at the level of the
visual cortex (area responsible for vision in the brain). It uses a non-invasive,
patient-specific treatment that purports to improve neuronal efficiency and induce
improvement in the overall ability to see due to a reduction in noise and increase in signal
strength. As visual perception quality depends both on the input received through the eye and
the processing in the visual cortex, NeuroVision's technology is hypothesized to compensate
for blurred (myopic) inputs, by enhancing neural processing.
We will conduct a clinical evaluation of the effectiveness of this system. The subject will
be exposed to a set of visual stimulations (pattern with black and white lines) and visual
threshold level will be obtained. The subject will look at these patterns on a computer. The
treatment will be applied in successive 30-40 minute sessions, administered 2-3 times a week,
for a total of 40 sessions. Every 5 sessions, subject's visual performance (visual acuity,
ability to see letters of varying size, and CSF, ability to see black and white lines of
varying contrast) will be tested in order to continuously monitor a subject's progress. At
the end of a session, the data will be sent to the NeuroVision Web Server. Proprietary
algorithmic software will analyze the patient's performance and progress and will generate
the parameters for the next treatment session. The purpose of the study is to assess the
effect on corrected or uncorrected visual performance following treatment.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04923841 -
Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine
|
N/A | |
| Active, not recruiting |
NCT04080128 -
Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control
|
N/A | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Completed |
NCT04604405 -
Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation
|
N/A | |
| Recruiting |
NCT05594719 -
The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow
|
N/A | |
| Completed |
NCT05594732 -
The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow
|
N/A | |
| Completed |
NCT04492397 -
Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI)
|
N/A | |
| Completed |
NCT04536571 -
Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses
|
N/A | |
| Completed |
NCT06046209 -
Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens
|
N/A | |
| Recruiting |
NCT06344572 -
Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia
|
Phase 3 | |
| Recruiting |
NCT05611294 -
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
|
N/A | |
| Completed |
NCT05656885 -
Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses
|
N/A | |
| Active, not recruiting |
NCT05534022 -
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression.
|
N/A | |
| Completed |
NCT03934788 -
the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens
|
N/A | |
| Completed |
NCT03701516 -
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
|
N/A | |
| Completed |
NCT05538754 -
Post-Market Evaluation of the EVO ICL
|
N/A | |
| Completed |
NCT03139201 -
Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens
|
N/A | |
| Completed |
NCT02555722 -
Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear
|
N/A | |
| Not yet recruiting |
NCT06009458 -
Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear
|
N/A | |
| Recruiting |
NCT05548478 -
Corneal Endothelial Cell Injury Induced by Mitomycin-C
|
N/A |